Effectiveness of etentalin, Ahura hyperactive and risperidone syrups in preschool children with attention deficit hyperactivity disorder

Phase 2

• Conditions: Attention Deficit Hyperactive Disorder(ADHD).; Attention-deficit hyperactivity disorder, predominantly hyperactive type; F90.1

• Registration Number: IRCT20160530028182N9
• Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

The age range of these children is 3 to 6 years
According to the DSM-5 diagnostic criterion, the child and adolescent psychiatrist should diagnose ADHD in children.

Exclusion Criteria

The presence of a serious physical illness, such as a seizure, based on parental history and clinical suspicion
Existence of comorbid psychiatric disorder other than confrontational disobedience disorder
Mental retardation based on clinical suspicion
Taking medications for Attention Deficit Hyperactivity Disorder in the last month
History of allergy to ethenalin and Ahura hyperactive

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Parent’s ADHD Rating scale Number. Timepoint: At the beginning of the study (baseline), 2 weeks, 4 weeks and 8 weeks after the study. Method of measurement: Parent’s ADHD Rating scale.;Clinical Global Impressions Number. Timepoint: At the beginning of the study (baseline), 2 weeks, 4 weeks and 8 weeks after the study. Method of measurement: Clinical Global Impressions.